Larkin Wadsworth
Sports Medicine · Saint Louis, MONPI 1851486575
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,305 of the $3,673 with a category attached, or 62.8%. 31 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 38.0% of the total.
Across 157 payments — averaging $23.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$1K
- Amgen$356
- Pfizer$329
- Johnson & Johnson$245
- Lilly USA, LLC$163
- Boehringer Ingelheim$150
- plus $1K from 25 others
Across 6,160 payments — averaging $4892.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$14.6M
- Pfizer$10M
- Seqirus USA Inc$1.1M
- GSK$1.1M
- Bavarian Nordic A/s$755K
- Boehringer Ingelheim$737K
- plus $1.9M from 16 others
What the payments were for
- Travel & lodging$1,23634%
- Food & beverage$2,30563%
- Gifts$1324%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 9 | $1,394 |
| Amgen(2 entities) | 24 | $356 |
| Pfizer | 19 | $329 |
| Johnson & Johnson(3 entities) | 20 | $245 |
| Lilly USA, LLC | 10 | $163 |
| Boehringer Ingelheim | 10 | $150 |
| AbbVie | 7 | $141 |
| Tosoh Bioscience, Inc. | 1 | $112 |
| Amarin Pharma, Inc. | 7 | $100 |
| AstraZeneca | 6 | $79 |
| GSK | 6 | $78 |
| Novo Nordisk | 4 | $60 |
| Paratek Pharmaceuticals, Inc. | 4 | $55 |
| Merck | 4 | $49 |
| Kowa Pharmaceuticals America, Inc. | 3 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Gilead | 2 | $24 |
| Sanofi Pasteur Inc. | 2 | $23 |
| GE HealthCare | 1 | $22 |
| Optos, Inc. | 1 | $21 |
| Elite Orthopedics, LLC | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Advanced Respiratory, Inc | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Novartis | 1 | $13 |
| Biogen | 1 | $11 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zilretta$1,136
- TSH, ST AIA-PACK$112
How this compares
$3,673 in reported general payments places this provider in the 60th percentile of 127 sports medicine providers in Missouri.
Other sports medicine in Saint Louis
- Derrick KnapikSaint Louis$72K
- Shalen KoukSaint Louis$46K
- Devon MyersSaint Louis$43K
- William McLaughlinSaint Louis$40K
- Richard SilvermanSaint Louis$27K
- Patrick ReardonSaint Louis$27K
- Brock KnappSaint Louis$24K
- Scott ZehnderSaint Louis$10K
- Christopher RothrockSaint Louis$6K
- Michael BurnsSaint Louis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.